Clinical Trial Update: Safety and Efficacy of Ga68-IAC PET/CT for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating Ga68-IAC PET/CT for diagnosis and clinical management in metastatic breast cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ga68-IAC PET/CT

Snippet

Sponsor: Advanced Imaging Projects, LLC | Conditions: Angiogenic Breast Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING